The Magazine for Sleep Professionals
Friday, May 1, 2026
EnsoData has announced a collaboration with Takeda to jointly develop and validate AI-based polysomnography (PSG) algorithms to support more accurate and scalable diagnosis of narcolepsy type 1 (NT1). Upon successful validation and regulatory clearance, EnsoData will pursue the clinical availability and release of AI algorithms to enable future access, use, […]
ProSomnus Sleep Technologies announced its inclusion on the prestigious Inc. 5000 list of fastest growing private companies in the USA. This is the fourth year that ProSomnus has earned a spot on the Inc. 5000 list. Persistent and robust organic demand for ProSomnus’s sleep apnea devices, as opposed to price […]
Nox Medical has announced the U.S. launch of the Nox SAS™ solution: an advanced EEG technology that enables simplified, clinically rigorous PSG testing in any setting. Designed for use with the Nox A1® PSG recorder, the Nox SAS solution eliminates the complexity of traditional PSG setups while maintaining clinical-grade signal […]
Nonin Medical has announced the launch of the Nonin Health® platform. The purpose-built cloud-based data ecosystem and software platform is designed for durable and home medical equipment (DME/HME) providers, sleep dentists, and sleep labs. With more than 1.5 million Americans currently requiring supplemental oxygen and millions more managing sleep-related breathing disorders, health care […]
Persante Healthcare has announced a strategic initiative to streamline efficiencies, improve communication, and position the company for scalable growth. As part of this initiative, Persante proudly welcomes Whitney Brenke as its newly appointed Chief Operating Officer (COO). Brenke brings over 15 years of executive leadership in healthcare operations, with a […]
ProSomnus Sleep Technologies announced significant progress on strategic programs. The key feature is the successful FDA registration of the company’s HWO2 buccal mucosal wellness oximeter. The ProSomnus HWO2 Device enables patients to monitor their nightly health and wellness during sleep, specifically, blood oxygen saturation, pulse rate and overall use time, […]
Nyxoah SA announced that the U.S. Food and Drug Administration (FDA) has approved the Genio system (hypoglossal nerve stimulation) for a subset of patients with moderate to severe OSA with an Apnea-Hypopnea Index (AHI) of greater than or equal to 15 and less than or equal to 65. Genio is […]
Insurance coverage and reimbursement for home sleep testing (HST) devices have improved in leaps and bounds over the last two decades, but unfortunately, denials and delays in care remain far too common. For many providers, figuring out a way forward can feel like navigating a labyrinth of policies and red […]
From the Dalai Lama’s claim that it is the “best meditation” to Benjamin Franklin’s insistence that it makes a person “healthy, wealthy, and wise,” a good night’s sleep has long been touted as the secret to a healthy life. And the American Heart Association (AHA) agrees. In 2022, the AHA added sleep […]
Topline: Patients with type 2 diabetes (T2D) who experienced sleep impairments, including short sleep duration, snoring, and insomnia symptoms, were more likely to face an increased risk for diabetes distress. In particular, daytime coping difficulties due to sleep problems showed a notably prominent association with diabetes distress. Methodology: Researchers in Norway conducted a cross-sectional […]
